False-negative core biopsy of the breast.

AJR Am J Roentgenol

Department of Radiology, Rush North Shore Medical Center, Skokie, IL 60076, USA.

Published: October 1998

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.171.4.9762970DOI Listing

Publication Analysis

Top Keywords

false-negative core
4
core biopsy
4
biopsy breast
4
false-negative
1
biopsy
1
breast
1

Similar Publications

Currently commercial colorimetric paper lateral flow immunoassays exhibit insufficient limit of detection (LOD) and limited clinical sensitivity toward the detection of SARS-CoV-2 antigens, which causes a high false negative rate. To mitigate this issue, a new plasmon-enhanced fluorescence probe was developed for paper lateral flow strips (PLFSs). The probe is made of a sandwich-structured Ag-core@silica@dye@silica-shell nanoparticle in which fluorescent dyes are sandwiched between the plasmonic Ag core and the silica outer shell, and the separation distance between the Ag core and the dye molecules is controlled by the silica space layer.

View Article and Find Full Text PDF

Tests for diagnosis of postpartum haemorrhage at vaginal birth.

Cochrane Database Syst Rev

January 2025

School of Medical Sciences, Department of Metabolism and Systems Science, WHO Collaborating Centre for Global Women's Health Research, University of Birmingham, Birmingham, UK.

Background: Postpartum haemorrhage (PPH) is the leading cause of maternal mortality worldwide. Accurate diagnosis of PPH can prevent adverse outcomes by enabling early treatment.

Objectives: What is the accuracy of methods (index tests) for diagnosing primary PPH (blood loss ≥ 500 mL in the first 24 hours after birth) and severe primary PPH (blood loss ≥ 1000 mL in the first 24 hours after birth) (target conditions) in women giving birth vaginally (participants) compared to weighed blood loss measurement or other objective measurements of blood loss (reference standards)?

Search Methods: We searched CENTRAL, MEDLINE, Embase, Web of Science Core Collection, ClinicalTrials.

View Article and Find Full Text PDF

Enhancing Clinical Applications by Evaluation of Sensitivity and Specificity in Whole Exome Sequencing.

Int J Mol Sci

December 2024

Bioinformatics Analysis Team, Research Core Center, Research Institute, National Cancer Center, Goyang 10408, Gyeonggi-do, Republic of Korea.

The cost-effectiveness of whole exome sequencing (WES) remains controversial due to variant call variability, necessitating sensitivity and specificity evaluation. WES was performed by three companies (AA, BB, and CC) using reference standards composed of DNA from hydatidiform mole and individual blood at various ratios. Sensitivity was assessed by the detection rate of null-homozygote (N-H) alleles at expected variant allelic fractions, while false positive (FP) errors were counted for unexpected alleles.

View Article and Find Full Text PDF

Photoelectrochemical biosensing platform based on switch of photocurrent polarity of CdS/Ni-CAT nanorod arrays by Au@CuO for highly selective and sensitive CEA detection.

Talanta

December 2024

State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, PR China. Electronic address:

Sensitive and accurate determination of tumour biomarkers is extremely important for early cancer diagnosis. Herein, a photoelectrochemical biosensor platform was constructed for ultrasensitive tumour biomarker detection by utilizing Au@CuO to switch the photocurrent polarity of CdS/Ni-catecholates metal-organic framework (Ni-CAT) nanorod arrays grown in situ on ITO. The Ni-CAT obtains close contact with ITO and forms a Z-scheme heterojunction with CdS, which improves the photogenerated electron transfer ability.

View Article and Find Full Text PDF

A high-performance core laboratory GFAP/UCH-L1 test for the prediction of intracranial injury after mild traumatic brain injury.

Am J Emerg Med

December 2024

Warfighter Readiness, Performance, and Brain Health Project Management Office (WRPBH PMO), US Army Medical Materiel Development Activity (USAMMDA), 1430 Veterans Drive, Fort Detrick, MD 21702, USA.

Article Synopsis
  • A blood biomarker panel including GFAP and UCH-L1 can potentially replace head CT scans for certain patients with traumatic brain injury (TBI), as it shows high sensitivity and negative predictive values.
  • In a study with 1,899 TBI patients, the panel accurately identified the presence of traumatic intracranial injury in most cases, with a low false-negative rate.
  • The core lab-based platform allows for rapid analysis of multiple samples, which is particularly useful in urgent situations like mass casualty events or busy emergency departments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!